Rapport Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Bostonmassachusettsfounded In 2022The Company Focuses On Discovering And Developing Precision Small Molecule Therapies For Central Nervous Systemcnsdisorderstheir Innovative Rap Technology Platform Is Built On Significant Discoveries Related To Brain Receptors And Their Associated Proteinsenabling The Creation Of Targeted Cns Drugs The Company S Pipeline Includes Several Promising Product Candidatesrap 219 Is An Investigational Small Molecule Aimed At Treating Focal Epilepsy And Other Cns Disorderswhile Rap 199 Features Unique Chemical And Pharmacokinetic Propertiesadditionallyrapport Therapeutics Is Developing Nicotinic Acetylcholine Receptornachrmodulators For Chronic Pain And Hearing Disordersthe Leadership Team Includes Experienced Professionals Dedicated To Advancing These Therapeutic Programs
No conferences found for this company.
| Company Name | Rapport Remedies |
| Country |
India
|
| Address | N/A |
| Telephone | N/A |
| N/A |
